IN2014CN04009A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN04009A IN2014CN04009A IN4009CHN2014A IN2014CN04009A IN 2014CN04009 A IN2014CN04009 A IN 2014CN04009A IN 4009CHN2014 A IN4009CHN2014 A IN 4009CHN2014A IN 2014CN04009 A IN2014CN04009 A IN 2014CN04009A
- Authority
- IN
- India
- Prior art keywords
- apoaequorin
- neurons
- subject
- injury due
- neuronal injury
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161559816P | 2011-11-15 | 2011-11-15 | |
| PCT/US2012/065291 WO2013074798A1 (fr) | 2011-11-15 | 2012-11-15 | Apoaéquorine pour réduire une lésion neuronale due à une ischémie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN04009A true IN2014CN04009A (fr) | 2015-10-23 |
Family
ID=47295186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4009CHN2014 IN2014CN04009A (fr) | 2011-11-15 | 2012-11-15 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20140294874A1 (fr) |
| EP (1) | EP2780027B1 (fr) |
| JP (1) | JP6181061B2 (fr) |
| KR (1) | KR102009932B1 (fr) |
| CN (1) | CN104244966B (fr) |
| AU (1) | AU2012340446B2 (fr) |
| BR (1) | BR112014011630A2 (fr) |
| CA (1) | CA2855719C (fr) |
| CY (1) | CY1119300T1 (fr) |
| DK (1) | DK2780027T3 (fr) |
| ES (1) | ES2643392T3 (fr) |
| HK (1) | HK1202417A1 (fr) |
| HR (1) | HRP20171532T1 (fr) |
| HU (1) | HUE035017T2 (fr) |
| IL (1) | IL232494B (fr) |
| IN (1) | IN2014CN04009A (fr) |
| LT (1) | LT2780027T (fr) |
| MX (1) | MX350259B (fr) |
| PL (1) | PL2780027T3 (fr) |
| PT (1) | PT2780027T (fr) |
| SG (1) | SG11201402364WA (fr) |
| SI (1) | SI2780027T1 (fr) |
| WO (1) | WO2013074798A1 (fr) |
| ZA (1) | ZA201403577B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA40959A (fr) * | 2014-11-11 | 2017-09-19 | Quincy Bioscience Llc | Compositions contenant de l'apoaéquorine et leurs procédés d'utilisation pour traiter l'inflammation neuronale |
| KR20180001229A (ko) | 2016-06-27 | 2018-01-04 | 삼성에스디아이 주식회사 | 이차 전지의 제조 방법 및 이를 이용한 이차 전지 |
| IL265515B (en) * | 2016-09-23 | 2022-09-01 | Quincy Bioscience Llc | Preparations that include apoquerin and vitamin D and methods of using them |
| RU2642961C1 (ru) * | 2017-02-21 | 2018-01-29 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ профилактики ишемии головного мозга |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
| GB0602992D0 (en) * | 2006-02-15 | 2006-03-29 | Morvus Technology Ltd | Methods, genes and proteins |
| WO2009114597A1 (fr) * | 2008-03-11 | 2009-09-17 | Quincy Bioscience, Llc | Compositions contenant de l’apoaequorine et leurs procédés d’utilisation |
| CN102137681B (zh) * | 2008-08-08 | 2014-12-03 | 埃姆诺医药有限公司 | 抗胰腺癌抗体 |
| US20110130336A1 (en) * | 2009-10-16 | 2011-06-02 | Quincy Bioscience, Llc | Method of treating ischemic injury using apoaequorin |
-
2012
- 2012-11-15 SG SG11201402364WA patent/SG11201402364WA/en unknown
- 2012-11-15 HU HUE12795955A patent/HUE035017T2/en unknown
- 2012-11-15 LT LTEP12795955.9T patent/LT2780027T/lt unknown
- 2012-11-15 KR KR1020147016261A patent/KR102009932B1/ko active IP Right Grant
- 2012-11-15 JP JP2014542463A patent/JP6181061B2/ja active Active
- 2012-11-15 ES ES12795955.9T patent/ES2643392T3/es active Active
- 2012-11-15 IN IN4009CHN2014 patent/IN2014CN04009A/en unknown
- 2012-11-15 EP EP12795955.9A patent/EP2780027B1/fr active Active
- 2012-11-15 US US14/358,274 patent/US20140294874A1/en not_active Abandoned
- 2012-11-15 AU AU2012340446A patent/AU2012340446B2/en active Active
- 2012-11-15 DK DK12795955.9T patent/DK2780027T3/en active
- 2012-11-15 CN CN201280066993.1A patent/CN104244966B/zh active Active
- 2012-11-15 BR BR112014011630A patent/BR112014011630A2/pt not_active Application Discontinuation
- 2012-11-15 WO PCT/US2012/065291 patent/WO2013074798A1/fr active Application Filing
- 2012-11-15 CA CA2855719A patent/CA2855719C/fr active Active
- 2012-11-15 SI SI201231064T patent/SI2780027T1/sl unknown
- 2012-11-15 PL PL12795955T patent/PL2780027T3/pl unknown
- 2012-11-15 PT PT127959559T patent/PT2780027T/pt unknown
- 2012-11-15 MX MX2014005798A patent/MX350259B/es active IP Right Grant
-
2014
- 2014-05-07 IL IL232494A patent/IL232494B/en active IP Right Grant
- 2014-05-16 ZA ZA2014/03577A patent/ZA201403577B/en unknown
-
2015
- 2015-03-20 HK HK15102850.8A patent/HK1202417A1/xx unknown
-
2017
- 2017-08-08 CY CY20171100851T patent/CY1119300T1/el unknown
- 2017-10-10 HR HRP20171532TT patent/HRP20171532T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2855719A1 (fr) | 2013-05-23 |
| HRP20171532T1 (hr) | 2017-11-17 |
| DK2780027T3 (en) | 2017-09-25 |
| JP2014533692A (ja) | 2014-12-15 |
| AU2012340446B2 (en) | 2017-08-31 |
| CA2855719C (fr) | 2021-10-26 |
| WO2013074798A1 (fr) | 2013-05-23 |
| HK1202417A1 (en) | 2015-10-02 |
| US20140294874A1 (en) | 2014-10-02 |
| EP2780027A1 (fr) | 2014-09-24 |
| KR20140097369A (ko) | 2014-08-06 |
| LT2780027T (lt) | 2017-10-25 |
| CN104244966B (zh) | 2019-01-11 |
| MX2014005798A (es) | 2014-05-30 |
| HUE035017T2 (en) | 2018-03-28 |
| EP2780027B1 (fr) | 2017-07-19 |
| CN104244966A (zh) | 2014-12-24 |
| MX350259B (es) | 2017-08-31 |
| BR112014011630A2 (pt) | 2017-06-27 |
| ES2643392T3 (es) | 2017-11-22 |
| CY1119300T1 (el) | 2018-02-14 |
| SI2780027T1 (sl) | 2017-11-30 |
| AU2012340446A1 (en) | 2014-05-29 |
| PT2780027T (pt) | 2017-10-04 |
| IL232494A0 (en) | 2014-06-30 |
| KR102009932B1 (ko) | 2019-08-12 |
| NZ624736A (en) | 2016-05-27 |
| SG11201402364WA (en) | 2014-09-26 |
| PL2780027T3 (pl) | 2017-11-30 |
| ZA201403577B (en) | 2015-07-29 |
| IL232494B (en) | 2019-03-31 |
| JP6181061B2 (ja) | 2017-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ700881A (en) | Compositions and methods comprising celecoxib or related compounds and dextromethorphan | |
| PH12016500953A1 (en) | Tricyclic compounds as anticancer agents | |
| IN2014DN09434A (fr) | ||
| MX2021001982A (es) | Administracion local y concomitante de nanoportadores sinteticos, tolerogenicos para reducir la hipersensibilidad tipo i y tipo iv. | |
| NZ631601A (en) | Solid forms of a thiophosphoramidate nucleotide prodrug | |
| MY166014A (en) | Combination therapy methods for treating proliferative diseases | |
| NZ630805A (en) | Pharmaceutical combinations comprising a thionucleotide analog | |
| JO3438B1 (ar) | مركبات بنزين مستبدلة بأريل أو أريل غير متجانس | |
| MX2019009437A (es) | Tratamiento de mielosupresion. | |
| MX2016004441A (es) | Tratamiento del cancer con una combinacion de plinabulina y taxano. | |
| NZ631144A (en) | Compositions and methods for transmucosal absorption | |
| MX2014002171A (es) | Tratamientos de combinacion para hepatitis c. | |
| PH12014501967B1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
| MX348708B (es) | Métodos para mejorar el desarrollo del cerebro y la función cognoscitiva al usar beta-hidroxi-beta-metilbutirato. | |
| IN2015DN03854A (fr) | ||
| MX336347B (es) | Metodo para atenuar los efectos adversos del farmaco usando los acidos grasos omega-3 como un vehiculo terapeutico parenteral del farmaco. | |
| NZ744323A (en) | Compositions comprising 15-hepe and methods of using the same | |
| CO7101244A2 (es) | Fenilimidazopirazoles sustituidos y su uso | |
| MX367926B (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
| WO2013173827A3 (fr) | Procédés et compositions pour inhiber des maladies du système nerveux central | |
| IN2014CN04009A (fr) | ||
| MX356317B (es) | Tratamiento de síntomas asociados a gastroparesia femenina. | |
| PE20151424A1 (es) | Compuesto farmaceutico para la prevencion y el tratamiento de un trastorno o una enfermedad cognitivos, neurodegenerativos o neuronales | |
| IN2014DN03010A (fr) | ||
| MX362905B (es) | Tratamiento de combinacion. |